Video analysis could personalize rehab for chemo nerve damage

NCT ID NCT07714278

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This study tests whether a personalized exercise program, guided by video-based movement analysis, can help people with chemotherapy-induced peripheral neuropathy (CIPN) — a common side effect causing numbness, tingling, and balance problems. The trial enrolls adults with breast, colorectal, or gynecological cancer who have CIPN symptoms. Participants are randomly assigned to either start the 4-week ReMAP exercise program immediately or receive usual care first, then switch. The main goal is to see if the program improves mobility and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a personalized rehabilitation exercise program guided by video-based movement analysis
What this could lead to
If effective, this approach could offer a non-drug way to improve mobility and reduce disability from chemotherapy-induced nerve damage.
What could go wrong
This is a relatively small, early-stage trial with no blinding, so results may be influenced by placebo effects or participant expectations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Seoul National University Bundang Hospital

    Seongnam-si, Gyeonggi-do, 13620, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.